PCRX: FY25 Deep Dive
FY25 revenue $726M; OI $28M; NI $7M; EPS $0.16.
Pacira BioSciences FY25 (Dec 31, 2025) at $726M revenue. OpInc $28M; NI $7M; EPS $0.16. Pharma — Pain Mgmt.
PCRXHealthcarePharma — Pain Mgmt·Sep 3, 2026·1 min read
PCRX: FY25 Deep Dive
Pacira BioSciences FY25 at $726M. NI $7M; EPS $0.16.
Related:PCRX
Want deeper analysis?
Ask drillr anything about PCRX — powered by SEC filings, earnings calls, and real-time data.
Try drillr.ai for free